Giarolla J - Search Results

1

Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties.

Santos SS, Gonzaga RV, Scarim CB, Giarolla J, Primi MC, Chin CM, Ferreira EI. Santos SS, et al. Among authors: giarolla j. Front Chem. 2022 Feb 14;9:734983. doi: 10.3389/fchem.2021.734983. eCollection 2021. Front Chem. 2022. PMID: 35237565 Free PMC article. Review.

2

Empowering Voices: Inspiring Women in Medicinal Chemistry.

Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen M, Garner AL, Georg G, Giarolla J, Goodwin NC, Grenier-Davies MC, Haskell-Luevano C, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, May-Dracka TL, Müller CE, Newman AH, Parmee E, Petter JC, Tamayo NA, Wexler RR, Bolognesi ML, Ripka A, Young W. Blanco MJ, et al. Among authors: giarolla j. ACS Med Chem Lett. 2024 Mar 8;15(4):424-431. doi: 10.1021/acsmedchemlett.4c00097. eCollection 2024 Apr 11. ACS Med Chem Lett. 2024. PMID: 38628790

3

Pteridine reductase (PTR1): initial structure-activity relationships studies of potential leishmanicidal arylindole derivatives compounds.

Silva JV, Sueyoshi S, Snape TJ, Lal S, Giarolla J. Silva JV, et al. Among authors: giarolla j. SAR QSAR Environ Res. 2023 Jul-Sep;34(8):661-687. doi: 10.1080/1062936X.2023.2247331. Epub 2023 Aug 22. SAR QSAR Environ Res. 2023. PMID: 37606690

4

Folate Pathway Inhibitors, An Underestimated and Underexplored Molecular Target for New Anti-tuberculosis Agents.

Vassiliades SV, Borges LG, Giarolla J, Parise-Filho R. Vassiliades SV, et al. Among authors: giarolla j. Mini Rev Med Chem. 2023;23(17):1711-1732. doi: 10.2174/1389557523666230206163154. Mini Rev Med Chem. 2023. PMID: 36744693 Review.

5

Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies.

Vaz ES, Vassiliades SV, Giarolla J, Polli MC, Parise-Filho R. Vaz ES, et al. Among authors: giarolla j. Eur J Clin Pharmacol. 2023 Jun;79(6):723-751. doi: 10.1007/s00228-023-03486-4. Epub 2023 Apr 20. Eur J Clin Pharmacol. 2023. PMID: 37081137 Free PMC article. Review.

6

Prodrugs for the treatment of neglected diseases.

Chung MC, Ferreira EI, Santos JL, Giarolla J, Rando DG, Almeida AE, Bosquesi PL, Menegon RF, Blau L. Chung MC, et al. Among authors: giarolla j. Molecules. 2007 Mar 19;13(3):616-77. doi: 10.3390/molecules13030616. Molecules. 2007. PMID: 18463559 Free PMC article. Review.

7

Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs.

Giarolla J, Pasqualoto KF, Rando DG, Zaim MH, Ferreira EI. Giarolla J, et al. J Mol Model. 2012 May;18(5):2257-69. doi: 10.1007/s00894-011-1244-8. Epub 2011 Oct 2. J Mol Model. 2012. PMID: 21965079

8

Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide.

Giarolla J, Pasqualoto KF, Ferreira EI. Giarolla J, et al. Mol Divers. 2013 Nov;17(4):711-20. doi: 10.1007/s11030-013-9467-5. Epub 2013 Aug 29. Mol Divers. 2013. PMID: 23990201

9

Drug design for neglected disease in Brazil.

Giarolla J, Ferreira EI. Giarolla J, et al. Mini Rev Med Chem. 2015;15(3):220-42. doi: 10.2174/138955751503150312122523. Mini Rev Med Chem. 2015. PMID: 25769971 Review.

10

Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.

Santos SS, de Araújo RV, Giarolla J, Seoud OE, Ferreira EI. Santos SS, et al. Among authors: giarolla j. Int J Antimicrob Agents. 2020 Apr;55(4):105906. doi: 10.1016/j.ijantimicag.2020.105906. Epub 2020 Jan 25. Int J Antimicrob Agents. 2020. PMID: 31987883 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters